EQUITY RESEARCH MEMO

Neuron Experts

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)45/100

Neuron Experts is a French contract research organization (CRO) founded in 2016, specializing in preclinical research on neuro-active compounds. The company utilizes primary neuronal cell cultures to model neurodegenerative diseases and neuronal impairment-induced skin disorders, offering advisory, R&D, and customized testing services for drug discovery in neuropharmacology and neurodermatology. Based in Paris, Neuron Experts targets the growing demand for specialized CRO services in neuroscience, leveraging its expertise to support pharmaceutical and biotech clients. Despite being privately held with no disclosed funding or valuation, the company occupies a niche in the preclinical CRO market, particularly for CNS and dermatology indications. Its stage is pre-clinical, indicating a focus on early-stage research support rather than proprietary drug development. The absence of commercial products or public pipelines suggests a service-based revenue model, which may provide steady but limited growth visibility. The company's profile completeness is low, and it has no recorded publication or FDA approval counts, reflecting its early stage and private nature. Given the competitive CRO landscape and lack of financial transparency, the conviction score is moderate.

Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)